Emergent Biosolutions
Price & Volume
Stats
See more52W Range | $1.82-$15.10 |
Market Cap | $540.2M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $1.1B |
Revenue Growth (YoY) | 8.6% |
Gross Profit (12 Mos) | $290.1M |
Diluted EPS | -$11.22 |
News
See moreYahoo Finance • 10 days ago
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
Yahoo Finance • 11 days ago
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Yahoo Finance • 19 days ago
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
Yahoo Finance • 20 days ago
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
About
CEO | Mr. Joseph C. Papa Jr. |
CFO | Mr. Richard S. Lindahl M.B.A. |
Address | 300 Professional Drive, Gaithersburg, MD, United States, 20879 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 900 |
